日本の造影剤インジェクター市場：2033年までの見通し - コンピューター断層撮影（CT）、磁気共鳴画像（MRI）、血管造影インジェクター

当レポートでは、日本の造影剤インジェクター市場について調査し、市場の概要とともに、2033年までの市場予測、主要参入企業のプロファイル、およびパイプライン製品などを提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 造影剤インジェクター市場、日本

• 造影剤インジェクター市場、日本、収益（100万米ドル）、2018年～2033年
• 造影剤インジェクター市場、日本、数量（台）、2018年～2033年
• 造影剤インジェクター市場、日本、平均価格（米ドル）、2018年～2033年
• 造影剤インジェクター市場、日本、収益別流通シェア（100万米ドル）、2023年
• 造影剤インジェクター市場、日本、収益別企業シェア（100万米ドル）、2023年

第4章 日本の造影剤インジェクター市場における主要企業の概要

• Nemoto Kyorindo Co Ltd
• Imaxeon Pty Ltd
• Guerbet SA

第5章 造影剤インジェクター市場のパイプライン製品

第6章 最近の動向

第7章 付録

List of Tables

• Table 1: Contrast Media Injectors Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Table 2: Contrast Media Injectors Market, Japan, Volume (Units), 2018-2033
• Table 3: Contrast Media Injectors Market, Japan, Average Price ($), 2018-2033
• Table 4: Contrast Media Injectors Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2023
• Table 5: Contrast Media Injectors Market, Japan, Company Share by Revenue ($m), USD Constant, 2023
• Table 6: Contrast Media Injectors Market Pipeline Products
• Table 7: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country

List of Figures

• Figure 1: Contrast Media Injectors Market, Japan, Revenue ($m), USD Constant, 2018-2033
• Figure 2: Contrast Media Injectors Market, Japan, Volume (Units), 2018-2033
• Figure 3: Contrast Media Injectors Market, Japan, Company Share (%) 2023

GlobalData's "Japan Contrast Media Injectors Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Japan Contrast Media Injectors market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Angiographic Injectors

The Japan Contrast Media Injectors Market report provides key information and data on -

• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Contrast Media Injectors Market.
• Global corporate-level profiles of key companies operating within the Japan Contrast Media Injectors Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Japan Contrast Media Injectors is segmented as follows -

• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Angiographic Injectors

Reasons to Buy

Japan Contrast Media Injectors Market report helps you to develop -

• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 What Is This Report About?
• 2.2 Contrast Media Injectors Market Segmentation
• 2.3 Definitions of Markets Covered in the Report

3 Contrast Media Injectors Market, Japan

• 3.1 Contrast Media Injectors Market, Japan, Revenue ($m), 2018-2033
• 3.2 Contrast Media Injectors Market, Japan, Volume (Units), 2018-2033
• 3.3 Contrast Media Injectors Market, Japan, Average Price ($), 2018-2033
• 3.4 Contrast Media Injectors Market, Japan, Distribution Share by Revenue ($m), 2023
• 3.5 Contrast Media Injectors Market, Japan, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in Japan, Contrast Media Injectors Market

• 4.1 Nemoto Kyorindo Co Ltd
  • 4.1.1 Company Overview
• 4.2 Imaxeon Pty Ltd
  • 4.2.1 Company Overview
• 4.3 Guerbet SA
  • 4.3.1 Company Overview

5 Contrast Media Injectors Market Pipeline Products

6 Recent Developments

• 6.1 Government and Public Interest
  • 6.1.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences

7 Appendix

• 7.1 Research Methodology
  • 7.1.1 Coverage
  • 7.1.2 Secondary Research
  • 7.1.3 Primary Research
  • 7.1.4 Market Modeling and Forecasting
  • 7.1.5 Company Share Analysis
  • 7.1.6 Distribution Share Analysis
  • 7.1.7 Benchmarking
• 7.2 GlobalData Consulting
• 7.3 Contact Us
• 7.4 Disclaimer